7Varela G, Ballesteros E, Jim6nez MF, et al.Cost- effectiveness analysis of prophylactic respiratory physiotherapy in pulmonary lobectomy. Eur J Cardiothorac Surg, 2006,29(2 ) : 216-220.
8Spichiger E, Miller Fruhlich C, Denhaerynck K, et al.Prevalence of symp- toms, with a focus on fatigue, and changes of symptoms over three months in outpatients receiving cancer chemotherapy. Swiss Med Wkly, 2011,8 ( 141 ) : 13303.
9Varela G,Ballesteros E,limBnez biF,et al.Oost-effectiveness analysis of prophylactic respiratory physiotherapy in pulmonary lobectomy[J].EurJ Cardiothorac Surg, 2012,29(2) : 216-220.
10SpichigerE,Miller FnihlichC,DenhckK,et al.Prevalencedsymp- toms,with a focus on fatigue,and changes ofsymptoms OVeF three months in outpatieills imivillg canoer chemotherapy[J].Swiss Med Wkly,2011,8: 1333.
